Samuel Reznik

Samuel Reznik has a wealth of work experience in the field of medicinal chemistry. Samuel began their professional career in 2004 as a Summer Research Assistant at Yale University. Samuel then moved on to the University of Pennsylvania in 2006, where they worked as an Undergraduate Research Assistant. In 2007, they began their doctoral studies at Columbia University, where they also served as a Teaching Assistant. In 2012, they joined Bristol-Myers Squibb as a Senior Research Investigator in Discovery Chemistry. In 2016, they moved to Agios Pharmaceuticals, where they served as a Principal Scientist and Associate Director of Medicinal Chemistry, and then as a Senior Scientist in Medicinal Chemistry. Most recently, in 2021, they were appointed Director of Medicinal Chemistry at Recludix Pharma.

Samuel Reznik attended Hopkins School from 1999 to 2003. Samuel then went on to the University of Pennsylvania, where they earned a BA in Chemistry from 2003 to 2007. Samuel continued their education at Columbia University, graduating with a PhD in Organic Chemistry in 2012.